Identity
HGNC
LOCATION
12p12.1
LOCUSID
ALIAS
HBLRR,LST-1,LST1,OATP-C,OATP1B1,OATP2,OATPC,SLC21A6
FUSION GENES
Non-annotated gene. Preliminary data : if you are an author who wish to write a full paper/card on this gene, contribute in submission tool
Other Information
Locus ID:
NCBI: 10599
MIM: 604843
HGNC: 10959
Ensembl: ENSG00000134538
Variants:
dbSNP: 10599
ClinVar: 10599
TCGA: ENSG00000134538
COSMIC: SLCO1B1
RNA/Proteins
| Gene ID | Transcript ID | Uniprot |
|---|---|---|
| ENSG00000134538 | ENST00000256958 | Q9Y6L6 |
| ENSG00000134538 | ENST00000256958 | A0A024RAU7 |
Expression (GTEx)
Pathways
Protein levels (Protein atlas)
PharmGKB
| Entity ID | Name | Type | Evidence | Association | PK | PD | PMIDs |
|---|---|---|---|---|---|---|---|
| PA10034 | bosentan | Chemical | VipGene | associated | 17496208 | ||
| PA10251 | atazanavir | Chemical | DataAnnotation | associated | |||
| PA128406956 | fluorouracil | Chemical | ClinicalAnnotation | associated | PD | 27234217 | |
| PA133950441 | hmg coa reductase inhibitors | Chemical | ClinicalAnnotation, GuidelineAnnotation, Literature, MultilinkAnnotation, Pathway, VipGene | associated | PK | PD | 11134001, 11477075, 12670950, 15970799, 16014768, 17177112, 17620857, 18650507, 1092254, 12811365, 15116054, 15226675, 16103896, 16678544, 17015053, 17108811, 17473846, 18650507, 18794729, 21178985, 21243006, 21928084, 22668755, 23361102, 23436703, 23708174, 23930675, 24263182, 24595600, 24598718, 24810685, 25350695, 25446771, 25630984, 25673568, 26086347, 26367500, 28812116 |
| PA134308647 | rosuvastatin | Chemical | ClinicalAnnotation, DataAnnotation, LabelAnnotation, Pathway, VariantAnnotation, VipGene | ambiguous | PK | PD | 16697742, 17473846, 17568401, 18794729, 22668755, 23930675, 25630984, 28812116 |
| PA142650384 | pitavastatin | Chemical | ClinicalAnnotation, LabelAnnotation, VipGene | associated | PK | 16595711, 15159445, 20175818, 23007012 | |
| PA143414738 | atrasentan | Chemical | ClinicalAnnotation, VariantAnnotation, VipGene | associated | PK | 16513443 | |
| PA164712509 | Arsenic compounds | Chemical | VipGene | associated | 16479312 | ||
| PA164742950 | olmesartan | Chemical | ClinicalAnnotation, VariantAnnotation, VipGene | associated | PK | 18641915 | |
| PA164743013 | caspofungin | Chemical | VipGene | associated | 15716364 | ||
| PA164748728 | mycophenolic acid | Chemical | ClinicalAnnotation | associated | PK | 25163792 | |
| PA164749431 | gemtuzumab ozogamicin | Chemical | ClinicalAnnotation | associated | PD | 22584460 | |
| PA164754789 | conjugated estrogens | Chemical | ClinicalAnnotation, VariantAnnotation | associated | 11477075 | ||
| PA164754992 | rocuronium | Chemical | ClinicalAnnotation | associated | PD | 25279974 | |
| PA165108401 | Acute coronary syndrome | Disease | ClinicalAnnotation | associated | PK | 25935875 | |
| PA165110775 | SN-38 | Chemical | ClinicalAnnotation | associated | PD | 18221820 | |
| PA165374673 | ticagrelor | Chemical | ClinicalAnnotation | associated | PK | 25935875 | |
| PA165817016 | Kidney Transplantation | Disease | ClinicalAnnotation | associated | PK | PD | 21142914, 21878834, 25163792 |
| PA166115842 | UGT1A1*28 | Haplotype | LabelAnnotation | associated | |||
| PA166119041 | drug-induced liver injury | Disease | ClinicalAnnotation, VariantAnnotation | ambiguous | PD | 22562052 | |
| PA166122590 | simeprevir | Chemical | LabelAnnotation | associated | |||
| PA166129446 | simvastatin acid | Chemical | ClinicalAnnotation | associated | PK | 25446771, 26367500, 28350522, 29469964 | |
| PA166153643 | rs1801131 | Variant | GuidelineAnnotation | associated | |||
| PA166153644 | rs1801133 | Variant | GuidelineAnnotation | associated | |||
| PA166154547 | rs2306283 | Variant | LabelAnnotation | associated | |||
| PA166154575 | rs4149032 | Variant | LabelAnnotation | associated | |||
| PA166154579 | rs4149056 | Variant | GuidelineAnnotation, LabelAnnotation | associated | |||
| PA166154581 | rs4149081 | Variant | GuidelineAnnotation | associated | |||
| PA166154633 | rs11045879 | Variant | GuidelineAnnotation | associated | |||
| PA166155721 | rs4148323 | Variant | LabelAnnotation | associated | |||
| PA166156544 | rs2231142 | Variant | LabelAnnotation | associated | |||
| PA166163391 | statin-related myopathy | Disease | ClinicalAnnotation | associated | PD | 28812116 | |
| PA166163418 | rucaparib | Chemical | LabelAnnotation | associated | |||
| PA166163438 | elbasvir / grazoprevir | Chemical | LabelAnnotation | associated | |||
| PA166182348 | elagolix | Chemical | LabelAnnotation | associated | |||
| PA166183785 | amlodipine / atorvastatin / perindopril arginine | Chemical | LabelAnnotation | associated | |||
| PA166184379 | letermovir | Chemical | ClinicalAnnotation, LabelAnnotation | associated | PK | 31022310 | |
| PA166184495 | ezetimibe / simvastatin | Chemical | LabelAnnotation | associated | |||
| PA166184498 | ezetimibe / rosuvastatin | Chemical | LabelAnnotation | associated | |||
| PA267 | ABCB1 | Gene | DataAnnotation | associated | |||
| PA378 | NR1I2 | Gene | DataAnnotation | associated | |||
| PA390 | ABCG2 | Gene | DataAnnotation | associated | |||
| PA443560 | Breast Neoplasms | Disease | ClinicalAnnotation, VariantAnnotation | associated | PK | PD | 27234217, 30520341 |
| PA443622 | Carcinoma, Non-Small-Cell Lung | Disease | ClinicalAnnotation | associated | PD | 18221820 | |
| PA443796 | Coronary Artery Disease | Disease | ClinicalAnnotation | associated | PD | 21178985, 21928084, 24595600, 28812116 | |
| PA443797 | Coronary Disease | Disease | ClinicalAnnotation | associated | PD | 22668755 | |
| PA443886 | Diabetes Mellitus | Disease | ClinicalAnnotation | associated | PD | 21178985, 21928084, 24595600, 28812116 | |
| PA443890 | Diabetes Mellitus, Type 2 | Disease | ClinicalAnnotation | associated | PD | 27271184 | |
| PA443899 | Diarrhea | Disease | ClinicalAnnotation | associated | PD | 27533851 | |
| PA443937 | Drug Toxicity | Disease | VariantAnnotation | associated | PD | ||
| PA444516 | Hypercholesterolemia | Disease | ClinicalAnnotation, VariantAnnotation | ambiguous | PK | PD | 17473846, 18781850, 18794729, 21178985, 21928084, 22016628, 22668755, 23263738, 23930675, 24595600, 25630984, 26334272, 26932749, 28812116 |
| PA444760 | Leukemia, Myeloid, Acute | Disease | ClinicalAnnotation | associated | PD | 22584460, 26663398 | |
| PA444997 | Muscular Diseases | Disease | ClinicalAnnotation | associated | PK | PD | 12811365, 15116054, 15226675, 16103896, 16678544, 17015053, 17108811, 17473846, 18650507, 18794729, 21243006, 21928084, 22668755, 23361102, 23708174, 23930675, 24263182, 24595600, 24598718, 25446771, 25630984, 25673568, 26086347, 26367500 |
| PA445062 | Neoplasms | Disease | ClinicalAnnotation, VariantAnnotation | ambiguous | PD | 18221820, 19390945, 25869015 | |
| PA445113 | Neutropenia | Disease | VariantAnnotation | not associated | PD | 19390945 | |
| PA445549 | Rhabdomyolysis | Disease | ClinicalAnnotation | associated | PK | PD | 12811365, 15116054, 15226675, 16103896, 16678544, 17015053, 17108811, 17473846, 18650507, 18794729, 21243006, 21928084, 22668755, 23361102, 23708174, 23930675, 24263182, 24595600, 24598718, 25446771, 25630984, 25673568, 26086347, 26367500 |
| PA445846 | Thrombocytopenia | Disease | ClinicalAnnotation | associated | PD | 27533851 | |
| PA445941 | Tuberculosis | Disease | ClinicalAnnotation, VariantAnnotation | ambiguous | PK | PD | 21709081 |
| PA446108 | Colorectal Neoplasms | Disease | ClinicalAnnotation | associated | PD | ||
| PA446155 | Precursor Cell Lymphoblastic Leukemia-Lymphoma | Disease | ClinicalAnnotation, VariantAnnotation | associated | PK | PD | 19901119, 23233662, 23652803, 24712521, 25098908, 28525903, 29683944 |
| PA447048 | Myopathy, Central Core | Disease | ClinicalAnnotation | associated | PK | PD | 17108811, 18650507, 21243006, 25446771 |
| PA447230 | HIV Infections | Disease | ClinicalAnnotation | associated | PK | PD | 32022294 |
| PA447288 | Essential hypertension | Disease | ClinicalAnnotation | associated | PD | ||
| PA448422 | amprenavir | Chemical | ClinicalAnnotation | associated | PK | ||
| PA448500 | atorvastatin | Chemical | ClinicalAnnotation, GuidelineAnnotation, Pathway, VariantAnnotation, VipGene | ambiguous | PK | PD | 15616150, 15970779, 10601278, 15970799, 16103896, 17473846, 18794729, 19374892, 19833260, 20040338, 21243006, 21928084, 22016628, 23263738, 23361102, 23876492, 26334272, 26932749 |
| PA448897 | cerivastatin | Chemical | ClinicalAnnotation, VariantAnnotation, VipGene | associated | PD | 15970799 | |
| PA449165 | cyclophosphamide | Chemical | ClinicalAnnotation | associated | PD | 27234217 | |
| PA449177 | cytarabine | Chemical | ClinicalAnnotation | associated | PD | 22584460, 26663398 | |
| PA449212 | daunorubicin | Chemical | ClinicalAnnotation | associated | PD | 26663398 | |
| PA449383 | docetaxel | Chemical | ClinicalAnnotation | associated | PD | 27234217 | |
| PA449412 | doxorubicin | Chemical | ClinicalAnnotation | associated | PD | 27234217 | |
| PA449456 | enalapril | Chemical | ClinicalAnnotation, VipGene | associated | PD | 16627748 | |
| PA449476 | epirubicin | Chemical | ClinicalAnnotation | associated | PD | 27234217 | |
| PA449552 | etoposide | Chemical | ClinicalAnnotation | associated | PD | 26663398 | |
| PA449594 | fenofibrate | Chemical | LabelAnnotation | associated | |||
| PA449655 | fludarabine | Chemical | ClinicalAnnotation | associated | PD | 22584460 | |
| PA449688 | fluvastatin | Chemical | ClinicalAnnotation, GuidelineAnnotation, Pathway, VariantAnnotation | ambiguous | PD | 18781850, 18794729 | |
| PA449961 | idarubicin | Chemical | ClinicalAnnotation | associated | PD | 22584460 | |
| PA450085 | irinotecan | Chemical | ClinicalAnnotation, VariantAnnotation | ambiguous | PD | 18221820, 19390945, 25869015 | |
| PA450112 | isoniazid | Chemical | VariantAnnotation | not associated | PD | ||
| PA450264 | lopinavir | Chemical | ClinicalAnnotation | associated | PK | PD | 32022294 |
| PA450272 | lovastatin | Chemical | ClinicalAnnotation, Pathway, VariantAnnotation, VipGene | associated | PK | PD | 15616150, 10601278, 16103896, 26020121 |
| PA450379 | mercaptopurine | Chemical | ClinicalAnnotation | associated | PD | 29683944 | |
| PA450428 | methotrexate | Chemical | ClinicalAnnotation, GuidelineAnnotation, MultilinkAnnotation, Pathway, VariantAnnotation, VipGene | associated | PK | PD | 11477075, 19901119, 21317831, 23233662, 23652803, 24712521, 25098908, 25999454, 28525903, 29683944 |
| PA450526 | mitoxantrone | Chemical | ClinicalAnnotation | associated | PD | 26663398 | |
| PA450566 | mycophenolate mofetil | Chemical | ClinicalAnnotation | associated | PK | PD | 21142914, 21878834 |
| PA450600 | nateglinide | Chemical | ClinicalAnnotation, Pathway | associated | PK | 18187595 | |
| PA450761 | paclitaxel | Chemical | VariantAnnotation | associated | PK | 30520341 | |
| PA451089 | pravastatin | Chemical | ClinicalAnnotation, Pathway, VariantAnnotation, VipGene | ambiguous | PK | PD | 15970799, 10601278, 12811365, 15116054, 15226675, 15864131, 15970799, 16103896, 16678544, 16722833, 17439540, 17622941, 18794729, 19776292, 19833260, 21851379, 25502615 |
| PA451234 | repaglinide | Chemical | ClinicalAnnotation, Pathway, VariantAnnotation, VipGene | ambiguous | PK | PD | 18187595, 15961978, 18187595, 18854776, 21327909, 29748863 |
| PA451250 | rifampin | Chemical | ClinicalAnnotation | associated | PK | PD | 19374892, 21709081, 22562052, 24420746 |
| PA451283 | rosiglitazone | Chemical | ClinicalAnnotation, Pathway | associated | PD | 27271184 | |
| PA451363 | simvastatin | Chemical | ClinicalAnnotation, GuidelineAnnotation, LabelAnnotation, Literature, MultilinkAnnotation, Pathway, VariantAnnotation, VipGene | ambiguous | PK | PD | 11134001, 11477075, 12670950, 15970799, 16014768, 17177112, 17620857, 18650507, 1092254, 17108811, 18650507, 18794729, 21243006, 22617227, 22668755, 23708174, 24598718, 24918167, 25446771 |
| PA451799 | troglitazone | Chemical | VipGene | associated | 14977862 | ||
| PA451848 | valsartan | Chemical | VipGene | associated | 16678545 | ||
| PA7000 | sorafenib | Chemical | ClinicalAnnotation | associated | PD | 27533851 |
References
| Pubmed ID | Year | Title | Citations |
|---|---|---|---|
| 37355503 | 2024 | SLCO1B1 Polymorphisms are Associated with the Susceptibility to Pulmonary Tuberculosis in Chinese Females. | 0 |
| 38279097 | 2024 | Associations between UGT1A1, SLCO1B1, SLCO1B3, BLVRA and HMOX1 polymorphisms and susceptibility to neonatal severe hyperbilirubinemia in Chinese Han population. | 0 |
| 38405139 | 2024 | The impact of SLCO1B1 rs4149056 on LDL-C target achievement after lipid lowering therapy optimization in men and women with familial hypercholesterolemia. | 2 |
| 38515340 | 2024 | Non-targeted metabolomics for the identification of plasma metabolites associated with organic anion transporting polypeptide 1B1 function. | 1 |
| 37355503 | 2024 | SLCO1B1 Polymorphisms are Associated with the Susceptibility to Pulmonary Tuberculosis in Chinese Females. | 0 |
| 38279097 | 2024 | Associations between UGT1A1, SLCO1B1, SLCO1B3, BLVRA and HMOX1 polymorphisms and susceptibility to neonatal severe hyperbilirubinemia in Chinese Han population. | 0 |
| 38405139 | 2024 | The impact of SLCO1B1 rs4149056 on LDL-C target achievement after lipid lowering therapy optimization in men and women with familial hypercholesterolemia. | 2 |
| 38515340 | 2024 | Non-targeted metabolomics for the identification of plasma metabolites associated with organic anion transporting polypeptide 1B1 function. | 1 |
| 36478296 | 2023 | Effects of the SLCO1B1 A388G single nucleotide polymorphism on the development, clinical parameters, treatment, and survival of multiple myeloma cases in a Polish population. | 1 |
| 36779498 | 2023 | Functional Characterization of Six SLCO1B1 (OATP1B1) Variants Observed in Finnish Individuals with a Psychotic Disorder. | 1 |
| 36964102 | 2023 | SLCO1B1 and SLCO1B3 genetic mutations in Taiwanese patients with Rotor syndrome. | 1 |
| 37101315 | 2023 | Effect of SLCO1B1 c.521T>C polymorphism on the lipid response to statins in people living with HIV on a boosted protease inhibitor-containing regimen. | 0 |
| 37221222 | 2023 | SLCO1B1*5 is protective against non-senile cataracts in cohort prescribed statins: analysis in a British-South Asian cohort. | 2 |
| 37222158 | 2023 | The frequency of major ABCG2, SLCO1B1 and CYP2C9 variants in Asian, Native Hawaiian and Pacific Islander women subgroups: implications for personalized statins dosing. | 0 |
| 37442606 | 2023 | Interaction of Human OATP1B1 with PDZK1 Is Required for Its Trafficking to the Hepatocyte Plasma Membrane. | 2 |
Citation
Dessen P
SLCO1B1 (solute carrier organic anion transporter family member 1B1)
Atlas Genet Cytogenet Oncol Haematol. 2010-08-01
Online version: http://atlasgeneticsoncology.org/gene/51592/slco1b1
